RBC Capital has significantly lowered its price target for Roper Technologies, highlighting investor concerns over slowing organic growth and soft spots in its software portfolio, while the company's own 2026 forecast falls short of Wall Street expectations.
Murphy Oil Corporation's stock fell nearly 5% last week following its fourth-quarter earnings report. While the company beat profit expectations, a revenue miss and a cautious production forecast for 2026 prompted a key analyst downgrade, overshadowing a dividend increase.
An AI analysis suggests Tesla shares could see modest gains, averaging around $456 by late April. As the EV leader navigates margin pressures and bets on AI-driven futures, investors weigh short-term technical forecasts against long-term transformative potential.
As generative AI tools become go-to sources for financial queries, GOBankingRates put their forecasting skills to the test. We compare their inflation predictions with expert analysis to see where the algorithms align with reality—and where they miss crucial context.
Western Digital's board has authorized an additional $4 billion for stock repurchases, capitalizing on surging demand for its memory chips from the artificial intelligence sector. The announcement follows strong quarterly forecasts and extends a rally that has seen the company's shares more than triple in value over the past year.
DaVita Inc. reported a milestone first profitable year for its Integrated Kidney Care (IKC) division, beating its own 2026 target. The kidney care giant provided robust 2026 guidance, forecasting 33% adjusted EPS growth, fueled by clinical initiatives and strategic partnerships aimed at reducing patient mortality and hospitalization rates.
Financial technology giant Broadridge Financial Solutions (NYSE: BR) reported fourth-quarter revenue and profit that comfortably exceeded Wall Street forecasts, driven by resilient demand for its core transaction processing and investor communications services.
PayPal Holdings Inc. announced the immediate departure of CEO Alex Chriss and a sobering earnings forecast, triggering a sharp sell-off in its shares as the payments giant grapples with intensifying competition and a slowdown in its core business.
Christopher O’Quinn, 36, died from blunt force trauma after a sledding incident involving a utility vehicle in Abbeville County during a winter outing with loved ones.
Industrial supplies giant W.W. Grainger (NYSE:GWW) reported fourth-quarter revenue that edged past Wall Street forecasts, though earnings per share fell short of consensus. The company's outlook suggests a period of moderated growth ahead.
Goldman Sachs raises its price target for Energy Transfer LP (ET) to $19, citing the upcoming USAC/J-W Power deal and adjustments in NGL and crude oil segment forecasts, while maintaining a Neutral rating amid near-term EBITDA headwinds.
Specialty materials maker ATI (NYSE: ATI) saw its shares surge after reporting fourth-quarter earnings that topped estimates, even as revenue came in slightly below Wall Street forecasts. The company pointed to strong demand in aerospace and defense as a key driver.
The maker of SuperPretzel and ICEE brands reported quarterly sales of $343.8 million, falling short of Wall Street forecasts and marking a year-over-year decline. Adjusted earnings also missed analyst expectations.
Merck & Co. reported solid fourth-quarter revenue growth driven by its blockbuster cancer drug Keytruda, but the pharmaceutical giant forecasts a slowdown in earnings growth as it absorbs billions in costs from recent acquisitions aimed at diversifying its pipeline ahead of Keytruda's patent expiration.
JPMorgan Chase analysts signal a potential top for the blistering silver rally, citing overextension and speculative fervor, while raising bullish forecasts for gold and Bitcoin as institutional interest pivots.
Plumas Bancorp announces a dividend increase to $0.33 per share, extending its nine-year payout history. While the yield remains modest, strong earnings coverage and robust EPS growth forecasts paint a picture of sustainable shareholder returns, even as the bank navigates share dilution concerns.
Agricultural giant Archer-Daniels-Midland reported a 13.7% year-over-year revenue decline to $18.56 billion for Q4 2025, missing market expectations. However, disciplined cost management helped deliver non-GAAP earnings of $0.87 per share, surpassing analyst forecasts by 9.2%.
Pfizer reported fourth-quarter revenue and profit that topped Wall Street forecasts, yet year-over-year sales dipped slightly. The pharmaceutical giant's results highlight the ongoing challenge of moving beyond its COVID-19 windfall.
BellRing Brands (NYSE: BRBR) reported fourth-quarter revenue that surpassed analyst expectations, though sales remained flat year-over-year. The company's full-year outlook and adjusted earnings also topped consensus forecasts, painting a picture of resilient performance amid a challenging market for consumer staples.
Pharmaceutical giant Merck & Co. reported fourth-quarter revenue that surpassed Wall Street forecasts, driven by robust demand for its key products. However, a more conservative full-year sales projection and a sharp expected decline in earnings for the coming year tempered the positive results, sending shares lower in after-hours trading.
